Abstract
Background: Capmatinib (CAP) is a drug that has been used to treat non-small cell lung cancer (NSCLC) in adults. Presently, its novel effects on skele......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
